Multi-Site STARgraft (10401) Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 111 participants.

Also called NCT07557862

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose other
Phase
Not applicable
Enrolled
  • 111 participants (planned count) (from the registry)
Sponsor
Healionics Corporation (from the registry)
Registry
  • NCT NCT07557862
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Brazil, Colombia (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07557862. Randomized; double masking; primary purpose other. Start 2026-10 (anticipated); primary completion 2027-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Multi-Site STARgraft (10401) Trial
Condition
End Stage Renal Disease (ESRD)
Intervention (Device)
STARgraft (10401)
Intervention (Device)
Gore Propaten
Lead sponsor
Healionics Corporation (class: industry)

Record details

Record id
cardio:ct-nct07557862
Content hash
5529256237d2e476b1e1429b3236ade6ce6bc771cfc2f0caac1978db0e5eae01